Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil

Veterinary Parasitology

Volumn 181, Issue 2-4, 2011, Pages 83-90

  Andrade, H M ^a   Toledo, V P C P ^a   Pinheiro, M B ^a   Guimaraes T M P D ^a   Oliveira, N C ^a   Castro, J A ^b   Silva, R N ^b   Amorim, A C ^b   Brandao R M S S ^b   Yoko, M ^b   Silva, A S ^b   Dumont, K ^b   Ribeiro, M L ^c   Bartchewsky, W ^c   Monte, S J H ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^c UNIVERSIDADE SÃO FRANCISCO   (Brazil)

Author keywords

Dogs; Miltefosine; Treatment; Visceral Leishmaniasis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; MILTEFOSINE; PARASITE ANTIGEN; PROTOZOAL DNA;

ANTIBODY BLOOD LEVEL; ARTICLE; BONE MARROW BIOPSY; BRAZIL; CHEMICAL PARAMETERS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOG; DRUG RESPONSE; FOLLOW UP; HUMORAL IMMUNITY; LEISHMANIA INFANTUM; LEISHMANIASIS; MOLECULAR WEIGHT; NONHUMAN; PARASITE LOAD; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIPROTOZOAL AGENTS; BRAZIL; DOG DISEASES; DOGS; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; PHOSPHORYLCHOLINE; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 80052522459     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2011.05.009     Document Type: Article

References (31)

1. Amusategui I., Sainz A., Rodriguez F., Tesouro M. A distribution and relationship between clinical and biopathological parameters in canine Leishmaniasis. Eur. J. Epidemiol. 2003, 18:147-156.
2. Andrade H.M., Toledo V.P.C.P., Mayrink W., Genaro O. Evaluation of the immune response and production of interferon in canine visceral leishmamniasis. Rev. Méd. Vét. 1999, 150:809-814.
3. Chamizo C., Moreno J., Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine Leishmaniasis. Vet. Immunol. Immunopathol. 2005, 103:67-75.
4. Croft S.L., Seifert K., Duchêne M. Antiprotozoal activities of phospholipids analogues. Mol. Biochem. Parasitol. 2003, 126:165-172.
5. Cuquerella M., Gómez-Muñoz M.T., Alunda J.M. Serum IgG response of Manchego lambs to infection with Haemonchus contortus and preliminary characterization of adult antigens. Vet. Parasitol. 1991, 38:131-143.
6. Disch J., Oliveira M., Orsini M., Rabello A. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral Leishmaniasis. Acta Trop. 2004, 92:279-283.
7. Dye C. The logic of visceral Leishmaniasis control. Am. J. Trop. Med. Hyg. 1996, 55:125-130.
8. Ikeda-García F.A., Lopes R.S., Marques F.J., Lima V.M.F., Morinishi C.K., Bonello F.L., Zanette M.F., Perri S.H.V., Feitosa M.M. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Vet. Parasitol. 2007, 143:254-259.
9. Clinical Biochemistry of Domestic Animals 1997, Academic Press, San Diego, 932 pp. J.J. Kaneko, J.W. Harvey, M.L. Bruss (Eds.).
10. Kaye P.M., Svensson M., Ato M., Maroof A., Polley R., Stager S., Zubairi S., Engwerda C.R. The immunopathology of experimental visceral Leishmaniasis. Immunol. Rev. 2004, 201:239-253.
11. Kemp K., Kemp M., Kharazmi A., Ismail A., Kurtzhals J.A., Hviid L., Theander T.G. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral Leishmaniasis. Clin. Exp. Immunol. 1999, 116:500-504.
12. Laemmli V.K. Cleavage of structural protein the assembly of the head of bacteriophage T4. Nature 1970, 27:680-685.
13. Mancianti F., Gramiccia M., Grandoni L., Pieri Studies on canine Leishmaniasis control. Evolution of infection of different clinical forms of canine Leishmaniasis following antimonial treatment. Trans. R. Soc. Trop. Med. Hyg. 1998, 82:566-567.
14. Manna L., Gravino A.E., Picillo E., Decaro N., Buonavoglia C. Leishmania DNA quantification by real-time PCR in naturally infected dogs treated with miltefosine. Ann. N.Y. Acad. Sci. 2008, 1149:358-360.
15. Manna L., Reale S., Picillo E., Vitale F., Gravino A.E. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol. Cytokine 2008, 44:288-292.
16. Manna L., Vitale F., Reale S., Picillo E., Neglia G., Vescio F., Gravino A.E. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis. Vet. J. 2008, 10.1016/j.tvjl.2008.08.009.
17. Mateo M., Maynard L., Vischer C., Bianciardi P., Miró G. Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis. Parasitol. Res. 2009, 105:155-162.
18. McLaren M.L., Lylliwhite J.E., Sirr S. A Laboratory Method for IFAT and ELISA 1980, The Ross Institute of Tropical Hygiene, London School of Hygiene and Tropical Medicine, London.
19. Ministério da Saúde, 2006. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Leishmaniose Visceral Grave Normas e Condutas Série A. Normas e Manuais Técnicos. Brasília - DF.
20. Miró G., Oliva G., Cruz I., Cañavate C., Mortarino M., Vischer C., Bianciardi P. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis. Vet. Dermatol. 2009, 20:397-404.
21. Oliva G., Scalone A., Foglia Manzillo V., Gramiccia M., Pagano A., Di Muccio T., Gradoni L. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naïve dogs exposed to three consecutive transmission seasons. J. Clin. Microbiol. 2006, 44:1318-1322.
22. Ovalle B.C., Porras de Quintana L., Muvdi Arenas S., Rios Parra M. PCR with kDNA as molecular target is a useful diagnostic test and the ITS rDNA molecular target is useful when the aim is to identify species Polymerase chain reaction with two molecular targets in mucosal leishmaniasis' diagnosis: a validation study. Mem. Inst. Oswaldo Cruz. 2007, 102:549-554.
23. Pasa S., Ozensoy Toz S., Voyvoda H., Ozbel Y. Clinical and serological follow-up in dogs with visceral leishmaniosis reated with allopurinol and sodium stibogluconate. Vet. Parasitol. 2005, 128:243-249.
24. Prina E., Roux E., Mattei D., Milon G. Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR. Microb. Infect. 2007, 9:1307-1315.
25. Rolão N., Cortes S., Rodrigues O.R., Campino L. Quantification of Leishmania infantum parasites in tissue biopsies by real-time polymerase chain reaction and polymerase chain reaction-enzyme-linked immunosorbent assay. J. Parasitol. 2004, 90:1150-1154.
26. Silva R.N., Amorim A.C., Brandão R.M., de Andrade H.M., Yokoo M., Ribeiro M.L., Bartchewsky W., Socorro-Silva A., de Castro J.A., do Monte S.J. Real-time PCR in clinical practice: a powerful tool for evaluating Leishmania chagasi loads in naturally infected dogs. Ann. Trop. Med. Parasitol. 2010, 104:137-143.
27. Soto J., Toledo J., Valda L., Balderrama M., Rea I., Parra R., Ardiles J., Soto P., Gomez A., Molleda F., Fuentelsaz C., Anders G., Sindermann H., Engel J., Berman J. Treatment of Bolivian mucosal Leishmaniasis with miltefosine. Clin. Infect. Dis. 2006, 44:350-356.
28. Sundar S., Rosenkaimer f., Makharia M.K., Goyal A.K., Mandal A.K., Voss A., Hilgard P., Murray H.W. Trial of oral miltefosine for visceral Leishmaniasis. Lancet 1998, 352:1821-1823.
29. Valladares J.E., Riera C., Gonzalez-Ensenyat P., Diez-Cascon A., Ramos G., Solano-Gallego L., Gallego M., Portus M., Arboix M., Alberola J. Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal ormulation. Vet. Parasitol. 2001, 97:15-21.
30. Wilson M.E., Jeronimo S.M.B., Pearson R.D. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb. Pathog. 2005, 38:147-160.
31. Woerly V., Maynard L., Sanquer A., Eun H.M. Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis. Parasitol. Res. 2009, 105:463-469.